Arcus Capital Partners’s Corteva CTVA Stock Holding History

Arcus Capital Partners’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-149	Closed	-$8.76K	–	168
2022 Q4	$8.76K	Buy	+149	New	+$9.43K	﹤0.01%	274

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Arcus Capital Partners's CTVA Position: Q1 2023 in Review

Arcus Capital Partners sold out of Corteva (CTVA) in Q1 2023, closing a stake of 149 shares — an estimated $8.76K sold.

Arcus Capital Partners first reported a position in CTVA in Q4 2022 and held it in 1 quarter. The position peaked at $8.76K in Q4 2022. 1,251 funds tracked by Wall St. Rank hold CTVA as of Q1 2023.

Arcus Capital Partners reported no remaining Corteva position as of Q1 2023 after selling out during the quarter.
Arcus Capital Partners sold 149 Corteva shares in Q1 2023, an estimated $8.76K.
Arcus Capital Partners first reported a position in Corteva in Q4 2022 and held it in 1 quarter.
Arcus Capital Partners's Corteva position peaked at $8.76K in Q4 2022.
1,251 funds tracked by Wall St. Rank held Corteva as of Q1 2023.

Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.